Psychopharmacological knowledge in pediatric practice. Common pharmaceuticals for child and adolescent psychiatrists;Psychopharmakologisches wissen für die pädiatrische praxis

Monatsschrift fur Kinderheilkunde

Volumn 160, Issue 7, 2012, Pages 672-676

  Kolch M G ^a,b   Fegert, J M ^b   Plener, P L ^b  

^a MARTIN LUTHER KRANKENHAUS   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Antidepressants; Antipsychotics; Child and adolescent psychiatry; Psychopharmacology; Stimulants

Indexed keywords

ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; HERBACEOUS AGENT; NEUROLEPTIC AGENT;

ARTICLE; CHILD PSYCHIATRY; GERMANY; HUMAN; OFF LABEL DRUG USE; PRESCRIPTION; PSYCHIATRIST; PSYCHOPHARMACOTHERAPY;

EID: 84863983965     PISSN: 00269298     EISSN: 14330474     Source Type: Journal    
DOI: 10.1007/s00112-012-2716-3     Document Type: Article

References (32)

1. Banaschewski T, Coghill D, Santosh P et al (2006) Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15(8):476-495 (Pubitemid 46020533)
2. Barzman DH, Findling RL (2008) Pharmacological treatment of pathologic aggression in children. Int Rev Psychiatry 20(2):151-157 (Pubitemid 351489517)
3. Bergh C, Ejderhamn J, Sodersten P (2003) What is the evidence basis for existing treatments of eating disorders? Curr Opin Pediatr 15(3):344-345 (Pubitemid 36578088)
4. Bridge JA, Iyengar S, Salary CB et al (2007) Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 297(15):1683-1696
5. Cooper WO, Habel LA, Sox CM et al (2011) ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 365:1896-1904. DOI 10.1056/NEJMoa1110212
6. De Hert M, Dobbelaere M, Sheridan EM et al (2011) Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice. Eur Psychiatry 26(3):144-158
7. Dubicka B, Hadley S, Roberts C (2006) Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. Br J Psychiatry 189:393-398 (Pubitemid 44683169)
8. Fegert JM, Kölch M, Zito MJ et al (2006) Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol 16(1/2):197-206
9. Glaeske G, Janhsen K (2007) der "GEK-Arzneimittel-Report 2007". Hippe, St. Augustin
10. Glaeske G, Schicktanz C, Janhsen K (2008) GEK-Arzneimittel-Report 2008. Auswertungsergebnisse der GEK-Arzneimitteldaten aus den Jahren 2006 bis 2007. GEK - Gmünder ErsatzKasse, Bereich Gesundheitsanalyse, Schwäbisch Gmünd
11. Glazener CM, Evans JH, Peto RE (2003) Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics). Cochrane Database Syst Rev 4: CD002238
12. Hammerness P, Georgiopoulos A, Doyle RL et al (2009) An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics. J Child Adolesc Psychopharmacol 19(5):493-499
13. Harrison CM, Britt HC (2005) Antidepressant use in children: a less depressing story. Med J Aust 182(2):92
14. Holtkamp K, Konrad K, Kaiser N et al (2005) A retrospective study of SSRI treatment in adolescent anorexia nervosa: insufficient evidence for efficacy. J Psychiatr Res 39(3):303-310 (Pubitemid 40255915)
15. Holtmann M (2009) Early onset bipolar disorders. Z Kinder Jugendpsychiatr Psychother 37(3):159-161
16. Kölch M, Fegert JM (2010) Ethics in child and adolescent psychiatric care: an international perspective. Int Rev Psychiatry 22(3):258-266
17. Kölch M, Bücheler R, Fegert JM, Gleiter CH (2006) Johanniskraut - eine evidenzbasierte Alternative in der Behandlung kindlicher und juveniler Depressionen. Psychopharmakotherapie 13(3):95-99 (Pubitemid 44112904)
18. Kölch M, Schnoor K, Fegert JM (2008) Ethical issues in psychopharmacology of children and adolescents. Curr Opin Psychiatry 21:598-605
19. Kölch M, Prestel A, Singer H et al (2009) Psychotropic medication in children and adolescents in Germany: prevalence, indications and psychopathological patterns. J Child Adolesc Psychopharmacol 19(6):765-770
20. Kölch M, Plener P, Fegert JM (2012) Psychopharmaka im Kindes-und Jugendalter. In: Gründer G, Benkert O (Hrsg) Handbuch der psychiatrischen Pharmakotherapie, 2. Aufl. Springer, Berlin Heidelberg New York, S 1185-1195
21. McDonagh MS, Peterson K, Thakurta S, Low A (2011) Drug class review: pharmacologic treatments for attention deficit hyperactivity disorder: final update 4 report. Drug Class Reviews. Oregon Health & Science University, Portland
22. Owen R, Sikich L, Marcus RN et al (2009) Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 124(6):1533-1540
23. Safer DJ, Zito JM (2006) Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents. J Child Adoles Psychopharmacol 16(1/2):159-169
24. Schubert I, Lehmkuhl G (2009) Increased antipsychotic prescribing to youths in Germany. Psychiatr Serv 60(2):269
25. Schwabe U, Paffrath D (2009) Arzneimittelverordnungsreport 2009. Springer, Berlin Heidelberg New York
26. Sikich L, Frazier JA, McClellan J et al (2008) Double-blind comparison of first-and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry 165(11):1420-1431
27. Vaughan B, Fegert JM, Kratochvil CJ (2009) Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder. Expert Opin Pharmacother 10(4):669-676
28. Whittington C, Kendall T, Fonagy P et al (2004) Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363:1341-1345 (Pubitemid 38529872)
29. Zito JM, Fegert JM, Jong-van den Berg LT de et al (2006) Antidepressant prevalence for youths: a multinational comparison. Pharmacoepidemiol Drug Saf 15(11):793-798 (Pubitemid 44762710)
30. Zito JM, Safer DJ, Valluri S et al (2007) Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. J Child Adolesc Psychopharmacol 17(2):195-203 (Pubitemid 46828915)
31. Zito JM, Safer DJ, Jong-van den Berg LT de et al (2008) A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health 2(1):26
32. Zito JM, Safer DJ, Sai D et al (2008) Psychotropic medication patterns among youth in foster care. Pediatrics 121(1):157-163